Blood RNA from metastatic Clear Cell Renal Carcinoma patients before or after treatment with nivolumab

ABSTRACT: Blood samples obtained at Cycle 1 Day 1, Cycle 1 Day 2 or at Cycle 2 Day 8 (i.e. before treatment, 24 hours after treatment or Week 4) from metastatic clear cell RCC patients treated with 0.2mpk, 3mpk or 10mpk (as 2nd or further line of therapy; Arms A,B,C) or 10mpk (as first line therapy; Arm D) of nivolumab (BMS-936558,MDX-1106) on Bristol-Myers Squibb clinical trial protocol CA209-009.

INSTRUMENT(S): Affymetrix Gene Titan

ORGANISM(S): Homo sapiens

SUBMITTER: Petra Ross-Macdonald 

PROVIDER: E-MTAB-3219 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress